| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology Research Center [A. V., S. L., R. M., V. A.] and Supratek Pharma, Inc. [V. A.], Institute Armand-Frappier, University of Quebec, 531 Boulevard des Prairies, Building 18, Laval, Quebec H7N 4Z3, Canada, and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198-6025 [A. K.]
The present study demonstrated that poly(oxypropylene) and poly(oxyethylene) block copolymer pluronic L61 (L61)-hypersensitized multidrugresistant CHRC5 Chinese hamster ovary cells and MCF-7/ADR human breast carcinoma cells to the cytotoxic action of doxorubicin (Dox). CHRC5 and MCF-7/ADR cells manifested 290- and 700-fold increases, respectively, in their sensitivity to Dox/L61 formulation compared with free Dox. Their sensitive counterparts Aux-B1 and MCF-7 displayed only marginal or no increase at all in their response to Dox/L61. The study of the drug transport performed by flow cytometry showed that L61 enhanced the drug uptake and reduced the P-glycoprotein-mediated drug efflux. Visualization of Dox subcellular distribution in CHRC5 cells by fluorescent microscopy revealed that Dox was sequestered in cytoplasmic vesicles, whereas incubation of the cells with Dox/L61 altered the drug compartmentalization by releasing the drug from these vesicles and shifting it to the nucleus. These findings suggested that the hypersensitive response of multidrug-resistant cells to the action of Dox/L61 was caused by an increase in the drug accumulation and changes in its subcellular distribution.
1 This work was supported by Industrial Research Assistance Program (IRAP) Grant 14113Q from the National Research Council of Canada.
2 To whom requests for reprints should be addressed, at Supratek Pharma, Inc., c/o Institute Armand-Frappier, University of Quebec, 531 Boulevard des Prairies, Building 18, Immunology Research Center, Laval, Quebec H7N 4Z3, Canada; Phone: (514) 686-5502; Fax: (514) 686-5504; E-mail: Valery__Alakhov@IAF.UQUEBEC.CA (V. A.); or Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, 600 South 42nd street, Omaha, NE 68198-6025; Phone: (402) 559-9364; Fax: (402) 559-5060; E-mail: Akabanov@UNMC.Edu. (A. K.)
Received 5/17/96. Accepted 7/ 3/96.
This article has been cited by other articles:
![]() |
C.-l. Dai, A. K. Tiwari, C.-P. Wu, X.-d. Su, S.-R. Wang, D.-g. Liu, C. R. Ashby Jr., Y. Huang, R. W. Robey, Y.-j. Liang, et al. Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2 Cancer Res., October 1, 2008; 68(19): 7905 - 7914. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, S. Kim, L. Li, S. Wang, K. Park, and J.-X. Cheng Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging PNAS, May 6, 2008; 105(18): 6596 - 6601. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Krupka, B. D. Weinberg, H. Wu, N. P. Ziats, and A. A. Exner Effect of Intratumoral Injection of Carboplatin Combined with Pluronic P85 or L61 on Experimental Colorectal Carcinoma in Rats Experimental Biology and Medicine, July 1, 2007; 232(7): 950 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Batrakova, S. Li, V. Y. Alakhov, D. W. Miller, and A. V. Kabanov Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 845 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Batrakova, S. Li, S. V. Vinogradov, V. Y. Alakhov, D. W. Miller, and A. V. Kabanov Mechanism of Pluronic Effect on P-Glycoprotein Efflux System in Blood-Brain Barrier: Contributions of Energy Depletion and Membrane Fluidization J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 483 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Batrakova, D. W. Miller, S. Li, V. Y. Alakhov, A. V. Kabanov, and W. F. Elmquist Pluronic P85 Enhances the Delivery of Digoxin to the Brain: In Vitro and in Vivo Studies J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 551 - 557. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |